These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 120422

  • 1. Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication.
    Rudd TG, Allen DR, Smith FD.
    J Nucl Med; 1979 Aug; 20(8):821-6. PubMed ID: 120422
    [Abstract] [Full Text] [Related]

  • 2. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
    Littlefield JL, Rudd TG.
    J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
    [Abstract] [Full Text] [Related]

  • 3. A clinical comparison of Tc-99m HEDP and Tc-99m MDP in the detection of bone metastases: concise communication.
    Fogelman I, Citrin DL, McKillop JH, Turner JG, Bessent RG, Greig WR.
    J Nucl Med; 1979 Feb; 20(2):98-101. PubMed ID: 430202
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical comparison of technetium-99m diphosphonate and pyrophosphate in bone scintigraphy: concise communication.
    Silberstein EB, Maxon HR, Alexander GW, Rauf C, Bahr GK.
    J Nucl Med; 1978 Feb; 19(2):161-3. PubMed ID: 203665
    [Abstract] [Full Text] [Related]

  • 7. A clinical comparison of Tc-99m HEDP and Tc-99m MDP.
    Coupal JJ, Kim EE.
    J Nucl Med; 1979 Aug; 20(8):896-7. PubMed ID: 120424
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
    Subramanian G, McAfee JG, Thomas FD, Feld TA, Zapf-Longo C, Palladino E.
    Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
    [Abstract] [Full Text] [Related]

  • 11. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G, Durez M, Bevilacqua M, Abramovici J, Robience Y.
    Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diphosphonate bone scanning agents--current concepts.
    Fogelman I.
    Eur J Nucl Med; 1982 Feb; 7(11):506-9. PubMed ID: 6217074
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer.
    Coleman RE, Meier CA, Rubens RD, Fogelman I.
    Nucl Med Commun; 1988 Jul; 9(7):481-5. PubMed ID: 3173907
    [Abstract] [Full Text] [Related]

  • 17. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications.
    Tan KF, Chang CH.
    Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712
    [No Abstract] [Full Text] [Related]

  • 18. Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP.
    Caner B, Kitapçl M, Unlü M, Erbengi G, Calikoğlu T, Göğüş T, Bekdik C.
    J Nucl Med; 1992 Mar; 33(3):319-24. PubMed ID: 1531501
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.